<Date>{23/09/2021}23.9.2021</Date>
<NoDocSe>B9‑0475/2021</NoDocSe>
PDF 132kWORD 48k

<TitreType>MOTION FOR A RESOLUTION</TitreType>

<TitreRecueil>pursuant to Rule 143 of the Rules of Procedure</TitreRecueil>


<Titre>on creating a European compensation fund for victims of the ‘COVID-19 vaccines’


</Titre>- Comirnaty (Pfizer, BioNTech)

- Janssen COVID-19 vaccine

- Spikevax (Moderna)

- Vaxzevria (AstraZeneca)

<Depute>Virginie Joron</Depute>


B9‑0475/2021

Motion for a European Parliament resolution on creating a European compensation fund for victims of the ‘COVID-19 vaccines’

The European Parliament,

 having regard to Rule 143 of its Rules of Procedure,

A. whereas the European Medicines Agency (EMA) has already recorded around a million cases of people experiencing adverse reactions from the COVID-19 vaccines:

- 435 779 due to the Pfizer BioNTech vaccine,

- 373 285 due to the AstraZeneca vaccine,

- 117 243 due to the Moderna vaccine,

- 27 694 due to the Janssen vaccine[1];

B. whereas these adverse reactions are sometimes severe; whereas around 75 000 people suffered from serious neurological effects as a result of taking the Pfizer vaccine;

C. whereas the EMA states that around 5 000 people have died in the EU as a result of taking the COVID-19 vaccines:

- 4 198 due to the Pfizer vaccine[2],

- 1 053 due to the AstraZeneca vaccine,

- 392 due to the Moderna vaccine,

- 138 due to the Janssen vaccine;

D. whereas the European Commission negotiated the purchase contracts and did not wish for the pharmaceutical companies to incur any liability;  whereas MEPs were not granted access to the contracts during the negotiations;

1. Calls on the Commission to create a European compensation fund for victims of the COVID-19 vaccines;

2. Instructs its President to forward this resolution to the Commission and the Member States.

Last updated: 14 October 2021Legal notice - Privacy policy